C Ellen van der Schoot
Overview
Explore the profile of C Ellen van der Schoot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
6302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van den Dijssel J, Konijn V, Duurland M, de Jongh R, Koets L, Veldhuisen B, et al.
Eur J Immunol
. 2025 Mar;
55(3):e202451565.
PMID: 40071711
Immunosenescence, age-related immune dysregulation, reduces immunity upon vaccinations and infections. Cytomegalovirus (CMV) infection results in declining naïve (T) and increasing terminally differentiated (T) T cell populations, further aggravating immune aging....
2.
Claireaux M, Elias G, Kerster G, Kuijper L, Duurland M, Paul A, et al.
Sci Adv
. 2025 Feb;
11(8):eado1331.
PMID: 39970201
Improving our understanding of B cell transition to memory B cells (MBCs) and antibody-secreting cells (ASCs) is crucial for clinical monitoring and vaccine strategies. To explore these dynamics, we compared...
3.
Nurmi V, Mayne R, Knight C, Almonacid-Mendoza H, Secret S, Estcourt L, et al.
J Infect
. 2025 Jan;
90(2):106412.
PMID: 39798805
Objectives: Convalescent plasma (CP) treatment of COVID-19 has shown significant therapeutic effect only when administered early. We investigated the importance of patient and CP seroprofiles on treatment outcome in REMAP-CAP...
4.
Kuijper L, Kreher C, Elias G, Claireaux M, Kerster G, Bos A, et al.
Front Immunol
. 2025 Jan;
15:1505719.
PMID: 39742271
Introduction: Upon infection, T cell-driven B cell responses in GC reactions induce memory B cells and antibody-secreting cells that secrete protective antibodies. How formation of specifically long-lived plasma cells is...
5.
van Zogchel L, Decarolis B, van Wezel E, Zappeij-Kannegieter L, Gelineau N, Schumacher-Kuckelkorn R, et al.
J Exp Clin Cancer Res
. 2024 Dec;
43(1):331.
PMID: 39722049
Background: Liquid biopsies offer less burdensome sensitive disease monitoring. Bone marrow (BM) metastases, common in various cancers including neuroblastoma, is associated with poor outcomes. In pediatric high-risk neuroblastoma most patients...
6.
Calandrini C, Verhagen O, Tissoudali A, Homburg C, Vessies J, Brussee M, et al.
Vox Sang
. 2024 Dec;
120(2):170-177.
PMID: 39647598
Background And Objectives: To test the performance of a new droplet digital polymerase chain reaction (ddPCR) non-invasive foetal blood group and platelet antigen genotyping assay in the setting of a...
7.
Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost-utility analysis
de Vos T, Tersteeg I, Lopriore E, Oepkes D, Porcelijn L, van der Schoot C, et al.
Vox Sang
. 2024 Dec;
120(2):178-187.
PMID: 39638612
Background And Objectives: Foetal and neonatal alloimmune thrombocytopenia (FNAIT) results from maternal platelet-directed antibodies and can result in severe intracranial haemorrhage (ICH) in foetuses and newborns. Screening for human platelet...
8.
Stutterheim J, van der Waarden R, de Groot-Kruseman H, Sonneveld E, de Haas V, Dandis R, et al.
Leukemia
. 2024 Sep;
38(11):2376-2381.
PMID: 39256602
Measurable residual disease (MRD) is regularly tested at later timepoints after the end of first consolidation (EOC) in children with acute lymphoblastic leukemia (ALL). The question remains whether this is...
9.
Luken J, Folman C, Meekers J, Lukens M, van der Schoot C, de Haas M
Br J Haematol
. 2024 Sep;
205(4):1599-1604.
PMID: 39252551
Extension with cE-matching of the transfusion policy for women under 45 years to prevent alloimmunization and hemolytic disease of the foetus and newborn (HDFN) was evaluated. After implementation of cEK-matching,...
10.
Meier R, Porcelijn L, Hofstede-van Egmond S, Caram-Deelder C, Coutinho J, Henskens Y, et al.
Antibodies (Basel)
. 2024 May;
13(2).
PMID: 38804303
Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but severe complication following COVID-19 vaccination, marked by thrombocytopenia and thrombosis. Analogous to heparin-induced thrombocytopenia (HIT), VITT shares similarities in anti-platelet factor 4...